Table 2

Summary characteristics of individuals with PMR and/or GCA

Total (n=3743)PMR (n=920)GCA (n=2823)
Demographics
 Age at baseline*, years74.1 (3.6)71.6 (3.1)74.9 (3.7)
 % Female67.8 (10.6)71.0 (10.7)66.7 (10.5)
Glucocorticoids use
 Cumulative dose, g7.6 (4.2)5.6 (3.3)8.2 (4.5)
 Duration of GC use, years2.4 (1.5)2.1 (1.2)2.5 (1.6)
Follow-up
 Duration, years5.9 (4.1)4.4 (3.3)6.4 (4.4)
  • All data are presented as a weighted mean (SD) across studies.

  • *Age at diagnosis (n=11), age at study inclusion (n=3), age unspecified in study (n=11).